Management of the Centre

The Director 

The BCGB’s director is Prof. Constanze Bonifer who has been a long-standing contributor to the fields of Genome Biology and Molecular Haemopoiesis with more than 100 publications and a multi-million pound grant income from both research council and charity sources. Her research straddles both fundamental and translational research. She has many years leadership experience from her time as the Head of Section of Experimental Haematology in Leeds and as a deputy committee chair for the BBSRC. She will be supported by deputy directors from the College of Life and Environmental Sciences and the College of Medicine and Dentistry (Ferenc Muller and John Colbourne). However, decisions in the BCGB will be made within a larger executive group that will cover multiple aspects of centre management, such as outreach, recruitment, training and equipment purchase.

The Board of Directors 

Constanze Bonifer: Director and representative for the College of Medicine

Ferenc Mueller: Deputy Director responsible for post-graduate students

John Colbourne: Deputy Director and representative for the College of Life Sciences

Malcolm Taylor: Lead for teaching

Jo Morris: Coordinator of scientific activities

Bryan Turner: Lead for outreach activities

Andrew Beggs: Responsible for liaison with clinical partners

Peter Cockerill: Responsible for Web site management 

The Scientific Advisory Board 

The BCGB management committee will be advised by a group comprising: 

Prof Wendy Bickmore: Head of the Chromosomes and Gene Expression Group, University of Edinburgh 

Prof Anne Ferguson-Smith: Head of the Stem cells and Epigenetic group, University of Cambridge

Prof Jesper Svejstrup: Head of the Transcription and DNA Repair group, The Francis Crick Institute 

Report from the Scientific Advisory Board Meeting 21 June 2016

The board members attended the recent inaugural symposium of BCGB. In their report they complimented us on the success of this meeting meeting and of the quality of science presented. We were advised to build on this success by holding a national scientific meeting with external invited speakers every 2 years.

The board found that the central themes that make up BCGB (transcription/chromatin – repair – replication – genomics) were very well interconnected, facilitating collaborations within the centre. The board acknowledged that BCGB was based on a well-interacting group of people, and suggested that the main group members should meet regularly to both present their science and to discuss issues that affect the running and research directions of the institute.

BCGB is already well supported by internal and external seminar programs, but it was recommended the BCGB should in addition hold internal scientific meetings every year where group leaders give an overview of their research.